Searched for
CYTOKINE RELEASE SYNDROME
Study suggests prior Zika infection may heighten risk of severe dengueA recent study suggests that individuals previously infected with Zika may face an increased risk of developing severe dengue and requiring...07 Feb, 2024, 07.45 PM IST- CDSCO approves India's first CAR-T cell therapy against certain blood cancersIndian company ImmunoACT, backed by drug maker Laurus Labs, has received approval from the Central Drugs Standard Control Organization for ...13 Oct, 2023, 05.02 PM IST
- Simple laboratory tests are playing an important role in risk stratification of Covid-19Patients with severe Covid-19, are prone to a cytokine storm, that can be fatal. A cytokine storm in an uncontrollable secretion of pro-inf...17 Nov, 2020, 03.37 PM IST
- ICMR reviewing use of tocilizumab for treatment of coronavirus pandemicTocilizumab is a rheumatoid arthritis drug manufactured by Swiss pharmaceutical company Roche under the brand name Actemra. The medication ...08 Sep, 2020, 07.23 AM IST
- Health ministry decides against including Itolizumab in clinical management protocols for COVID-19The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute Respiratory Di...26 Jul, 2020, 09.23 PM IST
- Biocon Q1 results: Net profit declines 28% to Rs 149 croreThe Bengaluru-headquartered biopharma company’s revenue was up 14% at Rs 1,690 crore during the quarter.24 Jul, 2020, 02.13 PM IST
- Biocon defends limited trial patients for Itolizumab nod, says followed science of "highest order"The company is marketing the drug as a replacement to Roche Pharma’s Tocilizumab (originally approved for rheumatoid arthritis) that is cur...14 Jul, 2020, 12.05 PM IST
- Biocon to take on Roche Pharma with its psoriasis drug to treat moderate to severe Covid patientsThe company is marketing the drug as a replacement to Roche’s tocilizumab (originally approved for rheumatoid arthritis) that is currently ...14 Jul, 2020, 12.03 PM IST
- Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vialNew Delhi, Jul 13 () Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatment of moderate to sev...13 Jul, 2020, 08.14 PM IST
- Biocon’s biosimilar for treating Covid-19: Patients responded positively, says Kiran Mazumdar-ShawThe Drug Controller General of India (DGCI) has permitted the Bengaluru-headquartered drug maker to market Itolizumab (ALZUMab) injection 2...12 Jul, 2020, 02.55 PM IST
- Biocon gets DCGI nod to use Itolizumab in moderate to severe Covid-19 patientsBiocon said the approval is based on the results from the successful conclusion of a randomized, controlled clinical trial at multiple hosp...11 Jul, 2020, 05.12 PM IST
- Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar classThe decision casts a shadow on other similar classes of drugs such as Tocilizumab by Swiss drug maker Roche pharma, that are under trial fo...07 Jul, 2020, 10.25 PM IST
- Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon BiologicsIt is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.16 Jun, 2020, 11.03 AM IST
- Biocon gets DCGI nod for device to treat critical COVID-19 patientsThe company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-infl...27 May, 2020, 12.57 PM IST
- Treating Covid-19: Clinical trials using arthritis drug get nod“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biol...12 May, 2020, 12.28 PM IST
- As virus advances, doctors rethink rush to ventilatorsThe picture is partial and evolving, but it suggests people with COVID-19 who have been intubated have had, at least in the early stages of...27 Apr, 2020, 12.08 PM IST
- Chronic fatigue syndrome biomarkers found: StudySan Francisco, Aug 7 (IANS) US researchers have identified biomarkers associated with the severity of chronic fatigue syndrome (CFS), which...07 Aug, 2017, 08.07 PM IST
Load More
